A month has gone by since the last earnings report for GSK (GSK). Shares have lost about 6.6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to ...

GSK’s Menveo vaccine protects against invasive meningococcal disease. Credit: MAXSHOT.PL/Shutterstock. The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of ...

GSK's liquid meningitis vaccine, Menveo, received approval from the European Commission to be sold in the European Union. The British pharmaceutical company said Wednesday that the fully liquid ...

Arexvy is an RSV vaccine currently authorised in the US and a further 35 countries. Credit: MargJohnsonVA/Shutterstock. GlaxoSmithKline (GSK) has received approval ...

The GSK (LSE:GSK) share price has fallen off its perch. So it may be a good time to research and consider the stock opportunity. I think the global biopharma company has been dripping with promise ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, positioning both companies to compete for that market and laying down a marker for ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...